about
Structure and oligomeric state of human transcription factor TFIIEArchitecture of the RNA polymerase II-TFIIF complex revealed by cross-linking and mass spectrometry.Quantification of Detergents Complexed with Membrane ProteinsBAG3 promotes pancreatic ductal adenocarcinoma growth by activating stromal macrophages.Overcoming bottlenecks in the membrane protein structural biology pipeline.Yeast virus-derived stimulator of the innate immune system augments the efficacy of virus vector-based immunotherapy.Expression and purification of native and functional influenza A virus matrix 2 proton selective ion channel.A Novel View on the Role of Intracellular Tails in Surface Delivery of the Potassium-Chloride Cotransporter KCC2TFIIH contains a PH domain involved in DNA nucleotide excision repair.Domain architecture of the p62 subunit from the human transcription/repair factor TFIIH deduced by limited proteolysis and mass spectrometry analysis.Molecular architecture of potassium chloride co-transporter KCC2.Dicarboxylate-Oside Detergents for Extraction, Overstabilization and Crystallization of Membrane Proteins.p52 Mediates XPB function within the transcription/repair factor TFIIH.Novel systematic detergent screening method for membrane proteins solubilization.The yin and yang of solubilization and stabilization for wild-type and full-length membrane protein.Enabling STD-NMR fragment screening using stabilized native GPCR: A case study of adenosine receptor.Dynamic Architecture of a Minimal RNA Polymerase II Open Promoter ComplexExternalized Keratin 8: A Target at the Interface of Microenvironment and Intracellular Signaling in Colorectal Cancer CellsFluorinated diglucose detergents for membrane-protein extractionLactobionamide-based fluorinated detergent for functional and structural stabilization of membrane proteinsBiochemical and biophysical characterization of purified native CD20 alone and in complex with rituximab and obinutuzumabNovel calixarene-based surfactant enables low dose split inactivated vaccine protection against influenza infectionHydrogenated Diglucose Detergents for Membrane-Protein Extraction and StabilizationStabilization of Human Multidrug Resistance Protein 4 (MRP4/ABCC4) Using Novel Solubilization AgentsFunctional Expression of Multidrug Resistance Protein 4 MRP4/ABCC4
P50
Q24309019-3EA283CF-EE31-4DD6-8AD6-C306E044E3CCQ27930175-A2949055-42D1-4566-B223-CAF68196BCF8Q30837921-44CA39A0-1F2C-410A-A20B-D7D040AAF91DQ36319886-3386990C-180D-41C9-9144-867947EA9843Q38855396-647A30C8-FCE4-4E89-9AE4-BE9B3FEB611EQ39020471-BA875EAF-A7D9-4C01-B116-6D18AB68FF69Q40459241-F7395985-F49D-44BD-AD94-F8092F6F8F2BQ41082928-63E31275-3543-45C0-9D43-6FBBC4EDB225Q44934836-18253799-A19A-4659-8F8A-3D4637B15705Q45143785-36D8A94E-6741-4134-A799-736A8E4331A6Q47118289-DEBDF51E-873F-4249-9BEF-6EDB9D251B03Q49609029-8122F3FC-274D-4A9B-B5DF-1D691A83C3F8Q50335569-AA15DA7F-B793-4B4D-BB58-BE3F6DF55315Q51325922-1A8E0329-B31A-4B98-A544-74D6E9B06DBBQ52686761-C7F8016E-8CAC-4100-9C6A-839985187989Q55401243-1F99A644-21DA-4E3F-B00C-F013FB083326Q56906686-D6FB3F05-3D26-4AFA-A2AC-56F353A8EFBCQ59797790-3707EE65-FD57-4B5D-91C9-79CF15182561Q88951238-ABDCA8E0-3D13-4304-AA44-48468900347AQ89728404-98015B82-2EC0-4738-98EE-F9C31965606AQ90241835-D1B0D55B-2761-4FA5-AC07-81165AAB9150Q90828539-9E113D93-872A-49D0-8CFE-BBEE8A78623EQ91610062-4E4DC513-2547-47BC-98B0-00F4238DAF36Q92415935-5541571A-DB8D-40C9-93F8-4B34CAE7C900Q92415963-77E35390-1EEC-4030-83F4-F700232ACF33
P50
description
researcher ORCID id 0000-0001-8170-0524
@en
wetenschapper
@nl
name
Anass Jawhari
@ast
Anass Jawhari
@en
Anass Jawhari
@es
Anass Jawhari
@nl
type
label
Anass Jawhari
@ast
Anass Jawhari
@en
Anass Jawhari
@es
Anass Jawhari
@nl
prefLabel
Anass Jawhari
@ast
Anass Jawhari
@en
Anass Jawhari
@es
Anass Jawhari
@nl
P108
P214
P106
P108
P214
P31
P496
0000-0001-8170-0524
P7859
viaf-188507621